Mostrar el registro sencillo del ítem

dc.contributor.author
González, Germán Esteban  
dc.contributor.author
Seropian, Ignacio Miguel  
dc.contributor.author
Krieger, Maria Laura  
dc.contributor.author
Palleiro, Jimena  
dc.contributor.author
Lopez Verrilli, María Alejandra  
dc.contributor.author
Gironacci, Mariela Mercedes  
dc.contributor.author
Cavallero, Carmen Susana  
dc.contributor.author
Wilensky, Luciana  
dc.contributor.author
Tomasi, Victor Hugo  
dc.contributor.author
Gelpi, Ricardo Jorge  
dc.contributor.author
Morales, Maria Celina  
dc.date.available
2020-04-14T20:18:17Z  
dc.date.issued
2009-07  
dc.identifier.citation
González, Germán Esteban; Seropian, Ignacio Miguel; Krieger, Maria Laura; Palleiro, Jimena; Lopez Verrilli, María Alejandra; et al.; Effect of early versus late AT 1 receptor blockade with losartan on postmyocardial infarction ventricular remodeling in rabbits; American Physiological Society; American Journal of Physiology - Heart and Circulatory Physiology; 297; 1; 7-2009; 375-386  
dc.identifier.issn
0363-6135  
dc.identifier.uri
http://hdl.handle.net/11336/102548  
dc.description.abstract
To characterize the temporal activation of the renin-angiotensin system after myocardial infarction (MI) in rabbits, we examined cardiac ANG II type 1 receptor (AT1R) expression and ANG II levels from 3 h to 35 days. The effects of losartan (12.5 mg·kg−1·day−1) on functional and histomorphometric parameters when treatment was initiated early (3 h) and late (day 15) post-MI and maintained for different periods of time [short term (4 days), midterm (20 days), and long term (35 days)] were also studied. AT1R expression increased in the MI zone at 15 and 35 days (P < 0.05). ANG II levels increased (P < 0.05) in the non-MI zone at 24 h and in the MI zone as well as in plasma at 4 days and then progressively decreased until 35 days. The survival rate was significantly lower in untreated MI and early long-term-treated animals. Diastolic pressure-volume curves in MI at 35 and 56 days shifted to the right (P < 0.05). This shift was even more pronounced in long-term-treated groups (P < 0.05). Contractility decreased (P < 0.05 vs. sham) in the untreated and long-term-treated groups and was attenuated in the midterm-treated group. The early administration of losartan reduced RAM 11-positive macrophages from 4.15 ± 0.05 to 3.05 ± 0.02 cells/high-power field (HPF; P < 0.05) and CD45 RO-positive lymphocytes from 2.23 ± 0.05 to 1.48 ± 0.01 cells/HPF (P < 0.05) in the MI zone at 4 days. Long-term treatment reduced the scar collagen (MI: 70.50 ± 2.35% and MI + losartan: 57.50 ± 2.48, P < 0.05), determined the persistency of RAM 11-positive macrophages (3.02 ± 0.13 cells/HPF) and CD45 RO-positive lymphocytes (2.77 ± 0.58 cells/HPF, P < 0.05 vs. MI), and reduced the scar thinning ratio at 35 days (P < 0.05). Consequently, the temporal expressions of cardiac AT1R and ANG II post-MI in rabbits are different from those described in other species. Long-term treatment unfavorably modified post-MI remodeling, whereas midterm treatment attenuated this harmful effect. The delay in wound healing (early reduction and late persistency of inflammatory infiltrate) and adverse remodeling observed in long-term-treated animals might explain the unfavorable effect observed in rabbits.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
American Physiological Society  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
MYOCARDIAL INFARCTION  
dc.subject
ANGIOTENSIN II  
dc.subject
RABBITS  
dc.subject
VENTRICULAR REMODELING  
dc.subject.classification
Fisiología  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Effect of early versus late AT 1 receptor blockade with losartan on postmyocardial infarction ventricular remodeling in rabbits  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2020-04-14T13:36:12Z  
dc.journal.volume
297  
dc.journal.number
1  
dc.journal.pagination
375-386  
dc.journal.pais
Estados Unidos  
dc.journal.ciudad
Bethesda  
dc.description.fil
Fil: González, Germán Esteban. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Fisiopatología Cardiovascular; Argentina  
dc.description.fil
Fil: Seropian, Ignacio Miguel. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Fisiopatología Cardiovascular; Argentina  
dc.description.fil
Fil: Krieger, Maria Laura. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Fisiopatología Cardiovascular; Argentina  
dc.description.fil
Fil: Palleiro, Jimena. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Fisiopatología Cardiovascular; Argentina  
dc.description.fil
Fil: Lopez Verrilli, María Alejandra. Universidad de Buenos Aires. Prog.de Invest.fisico Química (p); Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.description.fil
Fil: Gironacci, Mariela Mercedes. Universidad de Buenos Aires. Prog.de Invest.fisico Química (p); Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.description.fil
Fil: Cavallero, Carmen Susana. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Ciencias Biológicas. Cátedra de Fisiopatología; Argentina  
dc.description.fil
Fil: Wilensky, Luciana. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Fisiopatología Cardiovascular; Argentina  
dc.description.fil
Fil: Tomasi, Victor Hugo. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Fisiopatología Cardiovascular; Argentina  
dc.description.fil
Fil: Gelpi, Ricardo Jorge. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Fisiopatología Cardiovascular; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.description.fil
Fil: Morales, Maria Celina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Fisiopatología Cardiovascular; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.journal.title
American Journal of Physiology - Heart and Circulatory Physiology  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.1152/ajpheart.00498.2007  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://journals.physiology.org/doi/full/10.1152/ajpheart.00498.2007?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&